Research Archive — Page 4 of 136
-
June 3, 2026
Study questions standard screening test for amputation risk in veterans
In a review of the electronic health records of more than 223,000 veterans treated at Veterans Health Administration facilities, the researchers found that even modest decreases in the normal ABI correlated with a higher risk of major adverse limb events (MALE) requiring intervention, including amputation and revascularization (treatment to restore blood flow). -
June 3, 2026
Study challenges long-held practice of imaging for foreign body aspirations
As aspiration cases at Monroe Carell Jr. Children’s Hospital at Vanderbilt grew, a team of physicians sought to ensure that the most appropriate imaging tools were being used in the evaluation and diagnostic process for suspected aspirations. -
June 1, 2026
Vanderbilt ALS Research Center hosts second Reporting the Research event
Attendees gathered at Fat Bottom Brewing Company on May 20 for the event to raise awareness about the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS). -
June 1, 2026
Vanderbilt Health study explores GLP-1 therapies to improve asthma outcomes in patients with obesity
The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses. -
May 29, 2026
AI technique improves cancer gene discovery for breast and prostate cancer
The artificial intelligence model Enformer was retrained with tissue-specific datasets; this "transfer learning" approach outperformed the base model in identifying disease-associated genes. -
May 28, 2026
Oxford honors Russell Rothman with prestigious professorship
The one-year professorship is administered by the American Association of Rhodes Scholars and is awarded annually to a senior scholar “of the highest distinction” from the United States. -
May 28, 2026
Vanderbilt Health researchers call for pandemic prevention
The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.